Home›Search›Immuno-Oncology and Technology

Immuno-Oncology and Technology

Elsevier Inc. · United States · Est. 2019

ISSN2590-0188

SJR Q1✓ Scopus / SJR✓ DOAJ✓ Open Access

/ 100

Medium Risk

Score Breakdown

✓ Scopus Q1+25

✓ DOAJ Verified+15

Total50

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

SJR Score

2.43

H-Index

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIP

0.962

Total Works

1,229

Total Citations

1,808

2yr Mean Citedness

0.27

Free JIF alternative

Aims & Scope✦ Inferred from recent articles

This journal focuses on the intersection of immunology and oncology, particularly the development and application of technological advancements in cancer treatment. It explores the use of immune checkpoint inhibitors, chimeric antigen receptor (CAR) T-cell therapy, and other immunotherapies for various cancers, including melanoma, soft-tissue sarcoma, and acute myeloid leukemia. Research also investigates the tumor microenvironment, immune-related adverse events, and biomarkers for predicting treatment response and resistance.

AI-summarised from recent articles · verify on publisher page →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

weeks to review

Slow · median is 15 wks

SJR Rank

Top 25% in field

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published2019

Annual Volume~ 297 articles / year

StatusActive (last: 2026)

Total Publications1,229

Publisher OrgElsevier BV

OA Since2018

Visit Journal Website

Submission Info

Peer ReviewDouble-blind

Review Time~29 weeks

Acceptance Rate—

OA LicenseCC BY, CC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✗ No

📦 Long-term Preservation

PorticoPMCCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

9/12 · 75%

✅

Do you know the journal / publisher?

Elsevier Inc.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2590-0188

✅

Indexed in a trusted database?

Scopus, DOAJ

✅

Peer review process documented?

Double-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Portico, PMC, CLOCKSS

❌

Plagiarism detection in place?

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2019

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Immunology and AllergyQ1

OncologyQ1

Subject Classification

Scopus Categories

Immunology and AllergyOncology

Research Topics (OpenAlex)

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesCAR-T cell therapy researchLung Cancer Treatments and MutationsLung Cancer Research StudiesCancer Genomics and DiagnosticsDiverse Scientific and Economic StudiesColorectal Cancer Treatments and StudiesCancer Research and TreatmentsMonoclonal and Polyclonal Antibodies Research